Incidence and risk factors for central nervous system (CNS) metastasis (met) in patients (pts) with stage III melanoma treated with adjuvant (ADJ) anti-PD1 immunotherapy (IMT). This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results